Although sheep erythrocytes (SRBCs) are extensively used as an antigen in immunological studies, their histological distribution in lymphoid tissues has received little attention. The objective of this study was to determine the histological distribution of injected SRBCs in rat spleen. SRBCs were labelled with fluorescein isothiocyanate (FITC) to facilitate their identification in spleen sections with fluorescence microscopy. Rats received intravenous injections of FITC-labelled SRBCs and were sacrificed at various periods after injection. At 15 min, SRBCs were distributed throughout the marginal zone and red pulp. After 4 h, intact SRBCs were located mainly in the red pulp, while the marginal zone contained fluorescent flocculent material. At later periods this material was present in the periarterial lymphatic sheath (PALS) and in the light and dark zones of the germinal centers. By 12 h, the most intensely labelled areas in the white pulp were the crescent-shaped light zones. In 12 and 24 h, the PALS contained numerous foci of labelled granules. Some of the dark zones also contained label. After 48 h, the only areas containing label were the light zones of the germinal centers.

Keywords:
Spleen, Sheep erythrocytes, Antigen, Germinal center, Periarterial lymphatic sheath, Rat spleen
This content is only available via PDF.
© 1986 S. Karger AG, Basel
1986
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.